Cannara Biotech Inc. (LOVFF) Financials

LOVFF Assets vs Liabilities
DateAssetsLiabilities
Feb. 28, 2026 133.2 million 45.1 million
Nov. 30, 2025 124.4 million 44.8 million
Aug. 31, 2025 122.7 million 48.3 million
May 31, 2025 123.8 million 52.0 million

LOVFF Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
Feb. 28, 2026 -209825 799523
Nov. 30, 2025 2.4 million 1.2 million
Aug. 31, 2025 990334 228419
May 31, 2025 8.5 million 191225

LOVFF Net Income
Graph available only for paid members. Upgrade to see it.
DateNet Income
Feb. 28, 2026 1.2 million
Nov. 30, 2025 744121
Aug. 31, 2025 2.4 million
May 31, 2025 3.0 million

LOVFF Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
Feb. 28, 2026 16.1 million 18.5 million 180914
Nov. 30, 2025 11.8 million 18.3 million 230905
Aug. 31, 2025 10.4 million 20.5 million 288087
May 31, 2025 10.5 million 24.7 million 341264

LOVFF Shares Outstanding

No data available :(

LOVFF Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
Feb. 28, 2026 2.4 million 293667 5.6 million 2.1 million
Nov. 30, 2025 3.3 million 205759 5.7 million 1.9 million
Aug. 31, 2025 1.1 million 139075 4.6 million 2.0 million
May 31, 2025 1.6 million 128766 4.2 million 1.9 million

LOVFF Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
Feb. 28, 2026 19.9 million 11.4 million
Nov. 30, 2025 21.6 million 13.5 million
Aug. 31, 2025 20.8 million 11.7 million
May 31, 2025 19.9 million 10.5 million

LOVFF

Price: $1.30

52 week price:
1.10
1.47

Earnings Per Share: 0.09 USD

P/E Ratio: 15

Exchange: OQB

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Market Capitalization: 123.5 million

Links: